Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

COR

Cencora (COR)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:COR
DataOraFonteTitoloSimboloCompagnia
31/01/202521:59Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:CORCencora Inc
23/01/202522:27Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNYSE:CORCencora Inc
23/01/202522:21Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:CORCencora Inc
23/01/202522:17Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNYSE:CORCencora Inc
22/01/202522:07Edgar (US Regulatory)Form 8-K - Current reportNYSE:CORCencora Inc
13/01/202522:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CORCencora Inc
08/01/202513:30Business WireCencora Announces Date and Time for First Quarter Fiscal 2025 Earnings ReleaseNYSE:CORCencora Inc
02/01/202522:15Business WireCencora Completes Acquisition of Retina Consultants of AmericaNYSE:CORCencora Inc
20/12/202419:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:CORCencora Inc
09/12/202422:15Business WireCencora Closes $1.8 Billion Senior Notes OfferingNYSE:CORCencora Inc
04/12/202422:59Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:CORCencora Inc
03/12/202404:49Business WireCencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035NYSE:CORCencora Inc
02/12/202423:01Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:CORCencora Inc
02/12/202414:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:CORCencora Inc
26/11/202422:30Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:CORCencora Inc
26/11/202420:45Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:CORCencora Inc
06/11/202412:35Business WireCencora Reports Fiscal 2024 Fourth Quarter and Year End ResultsNYSE:CORCencora Inc
06/11/202412:30Business WireCencora Advances Specialty Leadership Through Acquisition of Retina Consultants of AmericaNYSE:CORCencora Inc
04/11/202414:30Business WireCencora Expands Enterprise Leadership Team with Two Senior AppointmentsNYSE:CORCencora Inc
01/10/202422:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:CORCencora Inc
01/10/202413:30Business WireCencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings ReleaseNYSE:CORCencora Inc
20/08/202422:05Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NYSE:CORCencora Inc
15/08/202413:30Business WireCencora Elects Frank Clyburn to Its Board of DirectorsNYSE:CORCencora Inc
02/08/202400:17Business WireCencora Announces Common Share Repurchase From Walgreens Boots AllianceNYSE:CORCencora Inc
02/08/202400:08Business WireWalgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of ProceedsNYSE:CORCencora Inc
31/07/202422:12Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:CORCencora Inc
31/07/202422:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:CORCencora Inc
31/07/202412:30Business WireCencora Reports Fiscal 2024 Third Quarter ResultsNYSE:CORCencora Inc
08/07/202414:35GlobeNewswire Inc.Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMDNYSE:CORCencora Inc
05/07/202422:15Business WireCencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings ReleaseNYSE:CORCencora Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:COR
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network